CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 4.96% on an annualized basis producing an average annual return of 17.73%. Currently, CRISPR Therapeutics has a market capitalization of $5.54 billion.
Buying $1000 In CRSP: If an investor had bought $1000 of CRSP stock 5 years ago, it would be worth $2,298.75 today based on a price of $69.75 for CRSP at the time of writing.
CRISPR Therapeutics’s Performance Over Last 5 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
